Carlos Cabañas

Prof. Dr. Carlos Cabañas

Immunology and Cell Biology, Centro de Biología Molecular Severo Ochoa, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
EWEduard Willms
Eduard Willms
Carlos CabañasCarlos Cabañas
Carlos Cabañas
IMImre Mäger
Imre Mäger
MWMatthew Wood
Matthew Wood
PVPieter Vader
Pieter Vader
Cells release membrane enclosed nano-sized vesicles termed extracellular vesicles (EVs) that function as mediators of intercellular communication by transferring biological information between cells. Tumor-derived EVs have emerged as important mediators in cancer development and progression, mainly through transfer of their bioactive content which can include oncoproteins, oncogenes, chemokine receptors, as well as soluble factors, transcripts of proteins and miRNAs involved in angiogenesis or inflammation. This transfer has been shown to influence the metastatic behavior of primary tumors. Moreover, tumor-derived EVs have been shown to influence distant cellular niches, establishing favorable microenvironments that support growth of disseminated cancer cells upon their arrival at these pre-metastatic niches. It is generally accepted that cells release a number of major EV populations with distinct biophysical properties and biological functions. Exosomes, microvesicles, and apoptotic bodies are EV populations most widely studied and characterized. They are discriminated based primarily on their intracellular origin. However, increasing evidence suggests that even within these EV populations various subpopulations may exist. This heterogeneity introduces an extra level of complexity in the study of EV biology and function. For example, EV subpopulations could have unique roles in the intricate biological processes underlying cancer biology. Here, we discuss current knowledge regarding the role of subpopulations of EVs in cancer development and progression and highlight the relevance of EV heterogeneity. The position of tetraspanins and integrins therein will be highlighted. Since addressing EV heterogeneity has become essential for the EV field, current and novel techniques for isolating EV subpopulations will also be discussed. Further dissection of EV heterogeneity will advance our understanding of the critical roles of EVs in health and disease.

1 January 1992 in Journal of Cell Biology
Verified
Journal Article
Open access
IDI Dransfield
I Dransfield
Carlos CabañasCarlos Cabañas
Carlos Cabañas
ACA Craig
A Craig
NHN Hogg
N Hogg
The integrin lymphocyte function-associated antigen-1 (LFA-1) expressed on T cells serves as a useful model for analysis of leukocyte integrin functional activity. We have assessed the role of divalent cations Mg2+, Ca2+, and Mn2+ in LFA-1 binding to ligand intercellular adhesion molecule-1 (ICAM-1) and induction of the divalent cation-dependent epitope recognized by mAb 24. Manganese strongly promoted both expression of the 24 epitope and T cell binding to ICAM-1 via LFA-1, suggesting that Mn2+ is able to directly alter the conformation of LFA-1 in a manner that favors ligand binding. Since Mn2+ also promotes functional activity of other integrins, parallels in mechanism of ligand binding may span the integrin family. In contrast, induction of 24 epitope expression by Mg2+ required removal of Ca2+ from T cell LFA-1 with EGTA. Furthermore, binding of mAb 24 to T cell LFA-1 in the presence of either Mn2+ or Mg2+ was found to be specifically inhibited by Ca2+, suggestive of a negative regulatory role for Ca2+ in the control of leukocyte integrin function. Analysis of T cell binding to ICAM-1 via LFA-1 in the presence of Mg2+ or Mn2+, confirmed that Ca2+ exerted inhibitory effects upon LFA-1 function. The implication of our findings is that Ca2+ bound with relatively high affinity to LFA-1 may serve to maintain an inactive state. Thus induction of function and 24 epitope expression may occur as a result of displacement of Ca2+ from leukocyte integrins or alternatively, such activators may be able to impose the required conformational change in the presence of bound Ca2+.

10 February 2016 in Nature
Verified
Journal Article
Closed access
CSChristian Schläger
Christian Schläger
HKHenrike Körner
Henrike Körner
MKMartin Krueger
Martin Krueger
SVStefano Vidoli
Stefano Vidoli
MHMichael Haberl
Michael Haberl
AFAlexander Flügel
Alexander Flügel

1 May 1996 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ALAlfonso Luque
Alfonso Luque
MGManuel Gómez
Manuel Gómez
WPWilma Puzon
Wilma Puzon
Yoshikazu TakadaYoshikazu Takada
Yoshikazu Takada
FSFrancisco Sánchez-Madrid
Francisco Sánchez-Madrid
Carlos CabañasCarlos Cabañas
Carlos Cabañas
The very late activation antigens (VLA) or β1 integrins mediate cell attachment to different extracellular matrix proteins and intercellular adhesions. The ligand binding activity of these adhesion receptors is not constitutive and can be regulated by temperature, presence of extracellular divalent cations, stimulatory monoclonal antibodies (mAbs), and cellular activation. We have generated three novel mAbs, HUTS-4, HUTS-7, and HUTS-21, recognizing specific epitopes on the common β1 subunit (CD29) of VLA integrins whose expression correlates with the ligand binding activity of these heterodimeric glycoproteins. This correlation has been demonstrated for several integrin heterodimers in different cell systems using a variety of extracellular and intracellular stimuli for integrin activation. Thus, the presence of micromolar concentrations of extracellular Mn, preincubation with the activating anti-β1 mAb TS2/16, and cell treatment with phorbol esters or calcium ionophores, induced the expression of the HUTS β1 epitopes on T lymphoblasts. Using a panel of human-mouse β1 chimeric molecules, we have mapped these epitopes to the 355-425 sequence of the β1 polypeptide. This segment represents therefore a novel regulatory region of β1 that is exposed upon integrin activation. Interestingly, binding of HUTS mAbs to partially activated VLA integrins results in maximal activation of these adhesion receptors and enhancement of cell adhesion to β1 integrin ligands collagen, laminin, and fibronectin.

4 May 1998 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
María Yáñez-MoMaría Yáñez-Mo
María Yáñez-Mo
AAArántzazu Alfranca
Arántzazu Alfranca
Carlos CabañasCarlos Cabañas
Carlos Cabañas
MMMónica Marazuela
Mónica Marazuela
RTReyes Tejedor
Reyes Tejedor
FSFrancisco Sánchez-Madrid
Francisco Sánchez-Madrid
Cell-to-cell junction structures play a key role in cell growth rate control and cell polarization. In endothelial cells (EC), these structures are also involved in regulation of vascular permeability and leukocyte extravasation. To identify novel components in EC intercellular junctions, mAbs against these cells were produced and selected using a morphological screening by immunofluorescence microscopy. Two novel mAbs, LIA1/1 and VJ1/16, specifically recognized a 25-kD protein that was selectively localized at cell–cell junctions of EC, both in the primary formation of cell monolayers and when EC reorganized in the process of wound healing. This antigen corresponded to the recently cloned platelet-endothelial tetraspan antigen CD151/PETA-3 (platelet-endothelial tetraspan antigen-3), and was consistently detected at EC cell–cell contact sites. In addition to CD151/PETA-3, two other members of the tetraspan superfamily, CD9 and CD81/ TAPA-1 (target of antiproliferative antibody-1), localized at endothelial cell-to-cell junctions. Biochemical analysis demonstrated molecular associations among tetraspan molecules themselves and those of CD151/ PETA-3 and CD9 with α3β1 integrin. Interestingly, mAbs directed to both CD151/PETA-3 and CD81/ TAPA-1 as well as mAb specific for α3 integrin, were able to inhibit the migration of ECs in the process of wound healing. The engagement of CD151/PETA-3 and CD81/TAPA-1 inhibited the movement of individual ECs, as determined by quantitative time-lapse video microscopy studies. Furthermore, mAbs against the CD151/PETA-3 molecule diminished the rate of EC invasion into collagen gels. In addition, these mAbs were able to increase the adhesion of EC to extracellular matrix proteins. Together these results indicate that CD81/TAPA-1 and CD151/PETA-3 tetraspan molecules are components of the endothelial lateral junctions implicated in the regulation of cell motility, either directly or by modulation of the function of the associated integrin heterodimers.

1 January 2013 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
LSLorena Sánchez-Martín
Lorena Sánchez-Martín
PSPaloma Sanchez-Mateos
Paloma Sanchez-Mateos
Carlos CabañasCarlos Cabañas
Carlos Cabañas